Indications for early aspirin use in acute ischemic stroke: A combined analysis of 40 000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial

Stroke

Volumn 31, Issue 6, 2000, Pages 1240-1249

  Chen, ZhengMing ^a   Sandercock, Peter ^b   Pan, HongCao ^a   Councell, Carl ^b   Collins, Rory ^a   Liu, LiSheng ^c   Xie, JingXian ^c   Warlow, Charles ^b   Peto, Richard ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c FUWAI HOSPITAL   (China)

Author keywords

Acute; Aspirin; Ischemic; Randomized controlled trials; Stroke

Indexed keywords

ACETYLSALICYLIC ACID;

ARTICLE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG USE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; META ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK FACTOR; STATISTICAL ANALYSIS; STROKE; TREATMENT INDICATION;

EID: 0034074730     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.6.1240     Document Type: Article

References (21)

1. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 1994;308:81-106.
2. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: a randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet. 1997;349:1641-1649.
3. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. Lancet. 1997; 349:1569-1581.
4. Bousser M-G. Aspirin or heparin immediately after a stroke? Lancet. 1997;349:1564-1565.
5. Lip GYH, Beevers DG. Interpretation of IST and CAST stroke trials. Lancet. 1997;350:442-443. Letter.
6. Chen ZM, Collins R, Peto R, Xie JX, Liu LS. Interpretation of IST and CAST stroke trials. Lancet. 1997;350:444. Letter.
7. Bradford APJ, Khan SA, Lees KR, McInees GT, Semple PE. Interpretation of IST and CAST stroke trials. Lancet. 1997;350:440-441. Letter.
8. Tan LB. Interpretation of IST and CAST stroke trials. Lancet. 1997; 350:443. Letter.
9. Czlonkowska A, Szpak GM. Interpretation of IST and CAST stroke trials. Lancet. 1997;350:441-442. Letter.
10. Counsell C, Sandercock P. The efficacy and safety of antiplatelet therapy in patients with acute presumed ischaemic stroke: a systematic review of the randomised trials comparing immediate antiplatelet therapy with control. In: Warlow C, Van Gijn J, Sandercock P, eds. Stroke Module, Cochrane Database of Systematic Reviews. Oxford, UK: Update Software; 1997 (updated quarterly; database on disk and CD-ROM).
11. Multicentre Acute Stroke Trial-Italy (MAST-I) Group. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet. 1995;346:1509-1514.
12. Early Breast Cancer Trialists' Collaborative Group. Treatment of Early Breast Cancer: Vol I: Worldwide Evidence 1985-1990. Oxford, UK: Oxford University Press; 1990.
13. He J, Whelton PK, Vu B, Klag MJ. Aspirin and risk of hemorrhagic stroke. JAMA. 1998;280:1930-1935.
14. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2:349-360.
15. Hill MD, Hachinski V. Stroke treatment: time is brain. Lancet. 1998; 352(suppl III): 10-14.
16. Baigent C, Chen Z, Collins R, Peto R, Sudlow C. Aspirin for suspected ischaemic stroke. Lancet. 1999;353:151-152. Letter.
17. Bednar MM, Gross CE. Antiplatelet therapy in acute cerebral ischaemia. Stroke. 1999;30:887-893.
18. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet. 1993;342:1255-1262.
19. Oxfordshire Community Stroke Project. The incidence of stroke in Oxfordshire. BMJ. 1983;287:713-717.
20. Li SC, Schoenberg BS, Wang CC, Cheng XM, Bolis CL, Wang KJ. Cerebrovascular disease in the People's Republic of China: epidemiologic and clinical features. Neurology. 1985;35:1708-1713.
21. Anonymous. Management soon after a stroke. Drug Ther Bull. 1998;36: 51-54.